Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Dehay

Showing results (51-60 of 100) with videos related to

Pageof 10
Sort By:
Scientific Reports|March 29, 2017
Checking behavior in rhesus monkeys is related to anxiety and frontal activityMarion Bosc, Bernard Bioulac, Nicolas Langbour, et al.
Human Gene Therapy Methods|August 2, 2018
Systemic Gene Delivery by Single-Dose Intracardiac Administration of scAAV2/9 and scAAV2/rh10 Variants in Newborn RatsLucie Chansel-Debordeaux, Mathieu Bourdenx, Nathalie Dutheil, et al.
Neurobiology of Disease|January 31, 2025
Current safety recommendations for handling mouse and human αsynuclein pre-formed fibrilsLauren Fielding, Marissa A Menard, Justin Roth, et al.
NPJ Parkinson'S Disease|August 1, 2024
Nigral ATP13A2 depletion induces Parkinson's disease-related neurodegeneration in a pilot study in non-human primatesJoanna Sikora, Sandra Dovero, Rémi Kinet, et al.
Neurobiology of Aging|August 13, 2021
Lack of limbic-predominant age-related TDP-43 encephalopathy (LATE) neuropathological changes in aged macaques with memory impairmentMorgane Darricau, Marie-Hélène Canron, Marion Bosc, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 2, 2016
Targeting α-synuclein: Therapeutic optionsBenjamin Dehay, Mickael Decressac, Mathieu Bourdenx, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 16, 2020
Nilotinib Fails to Prevent Synucleinopathy and Cell Loss in a Mouse Model of Multiple System AtrophyMiguel Lopez-Cuina, Paul A Guerin, Marie-Hélène Canron, et al.
Acta Neuropathologica Communications|January 11, 2017
Endosulfine-alpha inhibits membrane-induced α-synuclein aggregation and protects against α-synuclein neurotoxicityDaniel Ysselstein, Benjamin Dehay, Isabel M Costantino, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 2012
Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegenerationBenjamin Dehay, Alfredo Ramirez, Marta Martinez-Vicente, et al.
NPJ Parkinson'S Disease|April 12, 2025
Additive effect of distant Lewy bodies and tau seeds injections on nigral degeneration in macaquesMorgane Darricau, Valentine Kulifaj, Marie-Laure Arotcarena, et al.
Pageof 10

Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
Scientific Reports|March 29, 2017
Checking behavior in rhesus monkeys is related to anxiety and frontal activityMarion Bosc, Bernard Bioulac, Nicolas Langbour, et al.
Human Gene Therapy Methods|August 2, 2018
Systemic Gene Delivery by Single-Dose Intracardiac Administration of scAAV2/9 and scAAV2/rh10 Variants in Newborn RatsLucie Chansel-Debordeaux, Mathieu Bourdenx, Nathalie Dutheil, et al.
Neurobiology of Disease|January 31, 2025
Current safety recommendations for handling mouse and human αsynuclein pre-formed fibrilsLauren Fielding, Marissa A Menard, Justin Roth, et al.
NPJ Parkinson'S Disease|August 1, 2024
Nigral ATP13A2 depletion induces Parkinson's disease-related neurodegeneration in a pilot study in non-human primatesJoanna Sikora, Sandra Dovero, Rémi Kinet, et al.
Neurobiology of Aging|August 13, 2021
Lack of limbic-predominant age-related TDP-43 encephalopathy (LATE) neuropathological changes in aged macaques with memory impairmentMorgane Darricau, Marie-Hélène Canron, Marion Bosc, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 2, 2016
Targeting α-synuclein: Therapeutic optionsBenjamin Dehay, Mickael Decressac, Mathieu Bourdenx, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 16, 2020
Nilotinib Fails to Prevent Synucleinopathy and Cell Loss in a Mouse Model of Multiple System AtrophyMiguel Lopez-Cuina, Paul A Guerin, Marie-Hélène Canron, et al.
Acta Neuropathologica Communications|January 11, 2017
Endosulfine-alpha inhibits membrane-induced α-synuclein aggregation and protects against α-synuclein neurotoxicityDaniel Ysselstein, Benjamin Dehay, Isabel M Costantino, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 2012
Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegenerationBenjamin Dehay, Alfredo Ramirez, Marta Martinez-Vicente, et al.
NPJ Parkinson'S Disease|April 12, 2025
Additive effect of distant Lewy bodies and tau seeds injections on nigral degeneration in macaquesMorgane Darricau, Valentine Kulifaj, Marie-Laure Arotcarena, et al.
Pageof 10